Xilio Therapeutics Inc (XLO)
0.95
-0.07
(-6.86%)
USD |
NASDAQ |
Jun 17, 16:00
0.9476
0.00 (0.00%)
After-Hours: 20:00
Xilio Therapeutics Free Cash Flow: -53.87M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -53.87M |
| December 31, 2023 | -69.11M |
| September 30, 2023 | -74.41M |
| June 30, 2023 | -81.28M |
| March 31, 2023 | -81.92M |
| Date | Value |
|---|---|
| December 31, 2022 | -77.59M |
| September 30, 2022 | -76.40M |
| June 30, 2022 | -76.99M |
| March 31, 2022 | -80.04M |
| December 31, 2021 | -81.85M |
Free Cash Flow Range, Past 5 Years
-81.92M
Minimum
Mar 2023
-53.87M
Maximum
Mar 2024
-75.35M
Average
-77.29M
Median
Free Cash Flow Benchmarks
| Gilead Sciences Inc | 7.90B |
| FibroGen Inc | -274.68M |
| Avalo Therapeutics Inc | -26.83M |
| IGM Biosciences Inc | -194.58M |
| AEON Biopharma Inc | -- |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -10.50M |
| Cash from Financing (Quarterly) | 0.954M |
| Free Cash Flow Per Share (Quarterly) | -0.3762 |
| Free Cash Flow Yield | -205.9% |